In a troubled world economy and in a world threatened by the spread of epidemics, the Tunisian pharmaceutical sector which provides 50% of market needs in drugs and 60% in volume is posting a stronger growth.
The sector which comprised only 3 production units in 1987 boasts today 41 units (public and private) employing 3800 people, 37% of which are pharmacists reports the Tunisian daily newspaper “Le Temps”.These units produce locally 293 million dinars worth of medicine with 54% of licensed drugs and 46% of generic drugs.
The Tunisian pharmaceutical industry has been the focus of a cabinet meeting, held last week.
The meeting took initiatives aiming at achieving 60% of coverage of the domestic demand and boosting pharmaceutical exports by 2016.
Observers note that the growth of pharmaceutical industries in Tunisia, whose privatization started in 1989, is due to the setting up of a legal framework regulating the sector as well as fiscal and commercial incentives.
The sector imports medical products from European countries such as France, Italy, Switzerland, Denmark, the UK and Germany worth 346 million dinars and exports pharmaceutical products worth 320 million dinars to such countries as Libya, Algeria, France and Morocco as well as Mauritania, Senegal, Jordan, Yemen and Saudi Arabia.
Source: AllAfrica.com
Pharmaceutical Process Equipment
